<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Slovenia</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Slovenia.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/si.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Tularemia: a re-emerging zoonosis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-medcli-2026-107565-28481b3b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-medcli-2026-107565-28481b3b/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Tularemia is classified as a CDC Category A bioterrorism agent due to extreme virulence (infection possible with as few as 10 cells) and 30% mortality in untreated cases. The documented re-emergence across multiple Northern Hemisphere regions underscores the need for updated clinical awareness and early diagnostic capacity.</description>
    <category>Tularemia</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Tick-Borne Encephalitis Vaccine Effectiveness and Impact in Slovenia, 2019-2024.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15050503-22c8f2aa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15050503-22c8f2aa/</guid>
    <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
    <description>The data demonstrate significant disease reduction potential through routine immunization, though they simultaneously reveal substantial gaps in current community participation that warrant expanded promotional strategies.</description>
    <category>Tick-borne encephalitis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Tick-Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme-For Whom, When and Where?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-apa-70280-2f6f97a8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-apa-70280-2f6f97a8/</guid>
    <pubDate>Tue, 26 Aug 2025 00:00:00 GMT</pubDate>
    <description>Widespread adoption of the vaccine within national immunization schedules is advocated as a financially sustainable intervention that advances equitable protection for at-risk youth.</description>
    <category>Tick-borne encephalitis</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
